AMLX vs SNY
Amylyx Pharmaceuticals Inc (AMLX) versus SNY (SNY) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
SNY (SNY) common stock.
Latest reported AMLX revenue for 2025-12-31 was $0. Net income was -$144.7M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AMLX currently screens at market cap $561.6M.
SNY does not have a complete income-statement cache yet.
AMLX currently screens at market cap $561.6M. SNY currently screens at market cap $0.
Not investment advice. Open the AMLX and SNY stock pages for the full models.
Not investment advice.